Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Valrubicin bulk supplier for pharma manufacturers

Valrubicin 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intravesical solution

Available Strengths: 40 mg/mL

Reference Brands: Valstar (USA),

Category: Oncology Cancer Care

Valrubicin is a Oncology Cancer Care product available as Intravesical solution in strengths 40 mg/mL. It corresponds to the reference brands Valstar (USA),. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is an anthracycline anticancer agent used primarily for the treatment of carcinoma in situ (CIS) of the urinary bladder, particularly in patients who have not responded adequately to Bacillus Calmette-Guérin (BCG) therapy and for whom immediate cystectomy is not suitable. It is a semisynthetic analog of doxorubicin and is designed for intravesical administration, meaning it is delivered directly into the bladder through a catheter. This localized method of administration allows the drug to act directly on cancerous cells lining the bladder while minimizing systemic exposure.

Valrubicin works by interfering with the DNA replication process of rapidly dividing cancer cells. As an anthracycline derivative, it inhibits nucleic acid synthesis and disrupts cellular functions that are essential for tumor growth and survival. This mechanism helps slow or stop the progression of malignant cells within the bladder lining.

The medication is typically supplied as an intravesical solution and administered under the supervision of healthcare professionals experienced in oncology treatment. Valrubicin plays an important role in bladder cancer management by providing a bladder-preserving therapeutic option for patients who are not candidates for more invasive surgical procedures.

Valrubicin — third party manufacturing & bulk supply

Valrubicin 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Valrubicin listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Valrubicin →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Valrubicin is used for the treatment of carcinoma in situ (CIS) of the urinary bladder in patients who have not responded adequately to Bacillus Calmette-Guérin (BCG) therapy and for whom immediate cystectomy is not an option. It is administered directly into the bladder (intravesically) to act locally on cancer cells.

Valrubicin is a semisynthetic anthracycline derivative related to doxorubicin. It works by interfering with DNA replication and inhibiting the growth of cancer cells when applied directly inside the bladder.

The most recognized trade name of valrubicin is Valstar, primarily marketed in the United States for intravesical treatment of bladder cancer.

Valstar (valrubicin) has been marketed by companies involved in oncology and specialty pharmaceuticals in the United States, including Endo Pharmaceuticals in earlier commercialization.

The generic name of Valrubicin is valrubicin.

A well-known brand name of valrubicin is Valstar.

Valrubicin formulations such as Valstar are manufactured in regulated pharmaceutical manufacturing facilities approved for oncology products, primarily associated with U.S. pharmaceutical manufacturing and supply chains.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.